drugset / Trial / NCT05335252

Dronabinol After Arthroscopic Surgery

NCT05335252

Phase 3 Active not recruiting 30 enrolled Northwestern University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the proposed study is to evaluate the efficacy of dronabinol for postoperative pain after arthroscopic surgery of the knee. The investigators hypothesize that dronabinol will relieve pain, reduce opioid consumption and will result in few negative side effects. If this pilot study shows promising results the investigators will expand the trial to include additional arthroscopic surgeries (hip, shoulder) and other types of orthopaedic surgery.

Timeline

Start
2022-06-28
Primary completion
2026-12
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 5 mg